Prostanoid receptors in the human vascular wall

TheScientificWorldJournal

Volumn 7, Issue , 2007, Pages 1359-1374

  Norel, Xavier ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Aneurysm; Angiogenesis; Atherosclerosis; Endothelium; EP 1; EP2; Hypertension; Leukocyte; Migration; PGE2; PGI2; Proliferation; Prostacyclin; Prostaglandin; Smooth muscle; Thromboxane; Vasoconstriction; Vasodilatation

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CELL NUCLEUS RECEPTOR; CHEMOATTRACTANT; ILOPROST; NG 041; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTANOID RECEPTOR; RECEPTOR BLOCKING AGENT; ROSIGLITAZONE; THROMBOXANE; UNCLASSIFIED DRUG; UNIPROST;

AMINO ACID SEQUENCE; ANGIOGENESIS; BLOOD CELL; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CARCINOGENESIS; CARDIOVASCULAR SYSTEM; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CLINICAL TRIAL; CONTINUOUS INFUSION; CYTOPLASM; GENE EXPRESSION; HUMAN; INFLAMMATION; LEUKOCYTE; PATHOLOGY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PULMONARY HYPERTENSION; REVIEW; THROMBOCYTE; VASCULAR DISEASE;

GENE EXPRESSION; HUMANS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE; TUNICA INTIMA;

EID: 34548722249     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2007.184     Document Type: Review

References (161)

1. Kotani, M., Tanaka, I., Ogawa, Y., Usui, T., Tamura, N., Mori, K., Narumiya, S., Yoshimi, T., and Nakao, K. (1997) Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3). Genomics 40(3), 425-434.
2. Fujino, H. and Regan, J.W. (2003) Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer? Trends Pharmacol. Sci. 24(7), 335-340.
3. Zhu, T., Gobeil, F., Vazquez-Tello, A., Leduc, M., Rihakova, L., Bossolasco, M., Bkaily, G., Peri, K., Varma, D.R., Orvoine, R., and Chemtob, S. (2006) Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors. Can. J. Physiol. Pharmacol. 84(3-4), 377-391.
4. Bayston, T., Ramessur, S., Reise, J., Jones, K.G., and Powell, J.T. (2003) Prostaglandin E2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells. J. Vasc. Surg. 38(2), 354-359.
5. Leonhardt, A., Glaser, A., Wegmann, M., Schranz, D., Seyberth, H., and Nusing, R. (2003) Expression of prostanoid receptors in human ductus arteriosus. Br. J. Pharmacol. 138(4), 655-659.
6. Paul, B.Z., Ashby, B., and Sheth, S.B. (1998) Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells. Br. J. Haematol. 102(5), 1204-1211.
7. Boie, Y., Sawyer, N., Slipetz, D.M., Metters, K.M., and Abramovitz, M. (1995) Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem. 270(32), 18910-18916.
8. Funk, C.D., Furci, L., FitzGerald, G.A., Grygorczyk, R., Rochette, C., Bayne, M.A., Abramovitz, M., Adam, M., and Metters, K.M. (1993) Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J. Biol. Chem. 268(35), 26767-26772.
9. Regan, J.W., Bailey, T.J., Pepperl, D.J., Pierce, K.L., Bogardus, A.M., Donello, J.E., Fairbairn, C.E., Kedzie, K.M., Woodward, D.F., and Gil, D.W. (1994) Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46(2), 213-220.
10. An, S., Yang, J., Xia, M., and Goetzl, E.J. (1993) Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2. Biochem. Biophys. Res. Commun. 197(1), 263-270.
11. Abramovitz, M., Boie, Y., Nguyen, T., Rushmore, T.H., Bayne, M.A., Metters, K.M., Slipetz, D.M., and Grygorczyk, R. (1994) Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem. 269(4), 2632-2636.
12. Boie, Y., Rushmore, T.H., Darmon-Goodwin, A., Grygorczyk, R., Slipetz, D.M., Metters, K.M., and Abramovitz, M. (1994) Cloning and expression of a cDNA for the human prostanoid IP receptor. J. Biol. Chem. 269(16), 12173-12178.
13. Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., and Narumiya, S. (1991) Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 349(6310), 617-620.
14. Narumiya, S., Sugimoto, Y., and Ushikubi, F. (1999) Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79(4), 1193-1226.
15. Tsuboi, K., Sugimoto, Y., and Ichikawa, A. (2002) Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat. 68-69, 535-556.
16. Alhenc-Gelas, F., Tsai, S.J., Callahan, K.S., Campbell, W.B., and Johnson, A.R. (1982) Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells. Prostaglandins 24(5), 723-742.
17. McIntyre, T.M., Zimmerman, G.A., Satoh, K., and Prescott, S.M. (1985) Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J. Clin. Invest. 76(1), 271-280.
18. Walch, L., Gascard, J.P., Dulmet, E., Brink, C., and Norel, X. (2000) Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins. Br. J. Pharmacol. 130(1), 73-78.
19. Okatani, Y., Watanabe, K., Nakano, Y., and Sagara, Y. (1996) Relaxant effect of nitric oxide and prostacyclin on serotonin-induced vasocontraction of human umbilical artery. Acta Obstet. Gynecol. Scand. 75(2), 108-112.
20. Norel, X., Walch, L., Costantino, M., Labat, C., Gorenne, I., Dulmet, E., Rossi, F., and Brink, C. (1996) M1 and M3 muscarinic receptors in human pulmonary arteries. Br. J. Pharmacol. 119(1), 149-157.
21. Norel, X. and Brink, C. (2004) The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues. Pharmacol. Ther. 103(1), 81-94.
22. Brandt, R., Dembinska-Kiec, A., Korbut, R., Gryglewski, R.J., and Nowak, J. (1984) Release of prostacyclin from the human pulmonary vascular bed in response to cholinergic stimulation. Naunyn Schmiedebergs Arch. Pharmacol. 325(1), 69-75.
23. Norel, X., Haye-Legrand, I., Labat, C., Benveniste, J., and Brink, C. (1991) Antigen-induced contraction of human isolated lung preparations passively sensitized with monoclonal IgE: effects of indomethacin. Int. Arch. Allergy Appl. Immunol. 96(4), 368-375.
24. Dore, M., Cote, L.C., Mitchell, A., and Sirois, J. (1998) Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas. J. Histochem. Cytochem. 46(1), 77-84.
25. Yang, X., Sheares, K.K., Davie, N., Upton, P.D., Taylor, G.W., Horsley, J., Wharton, J., and Morrell, N.W. (2002) Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 27(6), 688-696.
26. Norel, X., Walch, L., Gascard, J.P., deMontpreville, V., and Brink, C. (2004) Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone. Br. J. Pharmacol. 142(4), 788-796.
27. Schonbeck, U., Sukhova, G.K., Graber, P., Coulter, S., and Libby, P. (1999) Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am. J. Pathol. 155(4), 1281-1291.
28. Spisni, E., Bianco, M.C., Griffoni, C., Toni, M., D'Angelo, R., Santi, S., Riccio, M., and Tomasi. V. (2003) Mechanosensing role of caveolae and caveolar constituents in human endothelial cells. J. Cell Physiol. 197(2), 198-204.
29. Topper, J.N., Cai, J., Falb, D., and Gimbrone, M.A., Jr. (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc. Natl. Acad. Sci. U. S. A. 93(19), 10417-10422.
30. Arnould, T., Thibaut-Vercruyssen, R., Bouaziz, N., Dieu, M., Remacle, J., and Michiels, C. (2001) PGF(2alpha), a prostanoid released by endothelial cells activated by hypoxia, is a chemoattractant candidate for neutrophil recruitment. Am. J. Pathol. 159(1), 345-357.
31. Ristimaki, A. and Viinikka, L. (1992) Modulation of prostacyclin production by cytokines in vascular endothelial cells. Prostaglandins Leukot. Essent. Fatty Acids 47(2), 93-99.
32. Mitchell, M.D., Romero, R.J., Lepera, R., Rittenhouse, L., and Edwin, S.S. (1990) Actions of endothelin-1 on prostaglandin production by gestational tissues. Prostaglandins 40(6), 627-635.
33. Gimbrone, M.A., Jr. and Alexander, R.W. (1975) Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science 189(4198), 219-220.
34. Cabre, F., Tost, D., Suesa, N., Gutierrez, M., Ucedo, P., Mauleon, D., and Carganico, G. (1993) Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists. Agents Actions 38(3-4), 212-219.
35. Maier, J.A., Hla, T., and Maciag, T. (1990) Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem. 265(19), 10805-10808.
36. Jones, D.A., Carlton, D.P., McIntyre, T.M., Zimmerman, G.A., and Prescott, S.M. (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268(12), 9049-9054.
37. Uracz, W., Uracz, D., Olszanecki, R., and Gryglewski, R.J. (2002) Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells. J. Physiol. Pharmacol. 53(4 Pt 1), 643-654.
38. Soler, M., Camacho, M., Escudero, J.R., Iniguez, M.A., and Vila, L. (2000) Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ. Res. 87(6), 504-507.
39. Wen, F.Q., Watanabe, K., and Yoshida, M. (1998) Eicosanoid profile in cultured human pulmonary artery smooth muscle cells treated with IL-1 beta and TNF alpha. Prostaglandins Leukot. Essent. Fatty Acids 59(1), 71-75.
40. Yamamoto, M., Aoyagi, M., Fukai, N., Matsushima, Y., and Yamamoto, K. (1999) Increase in prostaglandin E(2) production by interleukin-1beta in arterial smooth muscle cells derived from patients with moyamoya disease. Circ. Res. 85(10), 912-918.
41. Jourdan, K.B., Evans, T.W., Lamb, N.J., Goldstraw, P., and Mitchell, J.A. (1999) Autocrine function of inducible nitric oxide synthase and cyclooxygenase-2 in proliferation of human and rat pulmonary artery smooth-muscle cells: species variation. Am. J. Respir. Cell Mol. Biol. 21(1), 105-110.
42. Wen, F.Q., Watanabe, K., Tanaka, H., and Yoshida, M. (1997) Cytokines and lipopolysaccharide enhance basal and thrombin-stimulated production of PGI2 by cultured human pulmonary artery smooth muscle cells. Prostaglandins Leukot. Essent. Fatty Acids 56(3), 185-192.
43. Wen, F.Q., Watanabe, K., and Yoshida, M. (1997) Lipopolysaccharide and cytokines enhance bradykinin-stimulated production of PGI2 by cultured human pulmonary artery smooth muscle cells. Cell Biol. Int. 21(5), 321-327.
44. Zhang, Y., Cao, H.J., Graf, B., Meekins, H., Smith, T.J., and Phipps, R.P. (1998) CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts. J. Immunol. 160(3), 1053-1057.
45. Cipollone, F., Rocca, B., and Patrono, C. (2004) Cyclooxygenase-2 expression and inhibition in atherothrombosis. Arterioscler. Thromb. Vasc. Biol. 24, 1-10.
46. Katugampola, S.D. and Davenport, A.P. (2001) Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan. Br. J. Pharmacol. 134(7), 1385-1392.
47. Blindt, R., Bosserhoff, A.K., vom Dahl, J., Hanrath, P., Schror, K., Hohlfeld, T., and Meyer-Kirchrath, J. (2002) Activation of IP and EP(3) receptors alters cAMP-dependent cell migration. Eur. J. Pharmacol. 444(1-2), 31-37.
48. Wharton, J., Davie, N., Upton, P.D., Yacoub, M.H., Polak, J.M., and Morrell, N.W. (2000) Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation 102(25), 3130-3136.
49. Wallerstedt, S.M. and Bodelsson, M. (1997) Endothelium-dependent relaxation by substance P in human isolated omental arteries and veins: relative contribution of prostanoids, nitric oxide and hyperpolarization. Br. J. Pharmacol. 120(1), 25-30.
50. Malomvolgyi, B., Hadhazy, P., and Magyar, K. (1988) Relaxation by prostacyclin (PGI2) of human, dog and rabbit femoral artery strips. Interspecies difference. Biomed. Biochim. Acta 47(10-11), S125-128.
51. Chardigny, C., Jebara, V.A., Acar, C., Descombes, J.J., Verbeuren, T.J., Carpentier, A., and Fabiani, J.N. (1993) Vasoreactivity of the radial artery. Comparison with the internal mammary and gastroepiploic arteries with implications for coronary artery surgery. Circulation 88(5 Pt 2), II115-127.
52. Norel, X., Walch, L., and Brink, C. (2002) U46619 induced contractions: role of prostanoids and nitric oxide in human pulmonary vessels. Br. J. Pharmacol. Proc Sup, P064.
53. Ashton, A.W. and Ware, J.A. (2004) Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration. Circ. Res. 95(4), 372-379.
54. Nie, D., Lamberti, M., Zacharek, A., Li, L., Szekeres, K., Tang, K., Chen, Y., and Honn, K.V. (2000) Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem. Biophys. Res. Commun. 267(1), 245-251.
55. Daniel, T.O., Liu, H., Morrow, J.D., Crews, B.C., and Marnett, L.J. (1999) Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 59(18), 4574-4577.
56. Arner, M., Uski, T., and Hogestatt, E.D. (1994) Endothelium dependence of prostanoid-induced relaxation in human hand veins. Acta Physiol. Scand. 150(3), 267-272.
57. Bhattacharya, M., Peri, K., Ribeiro-da-Silva, A., Almazan, G., Shichi, H., Hou, X., Varma, D.R., and Chemtob, S. (1999) Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J. Biol. Chem. 274(22), 15719-15724.
58. Gobeil, F., Jr., Dumont, I., Marrache, A.M., Vazquez-Tello, A., Bernier, S.G., Abran, D., Hou, X., Beauchamp, M.H., Quiniou, C., Bouayad, A., Choufani, S., Bhattacharya, M., Molotchnikoff, S., Ribeiro-Da-Silva, A., Varma, D.R., Bkaily, G., and Chemtob, S. (2002) Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors. Circ. Res. 90(6), 682-689.
59. Lim, H. and Dey, S.K. (2002) A novel pathway of prostacyclin signaling-hanging out with nuclear receptors. Endocrinology 143(9), 3207-3210.
60. Moraes, L.A., Piqueras, L., and Bishop-Bailey, D. (2006) Peroxisome proliferator-activated receptors and inflammation. Pharmacol. Ther. 110(3), 371-385.
61. Marx, N., Schonbeck, U., Lazar, M.A., Libby, P., and Plutzky, J. (1998) Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res. 83(11), 1097-1103.
62. Goetze, S., Eilers, F., Bungenstock, A., Kintscher, U., Stawowy, P., Blaschke, F., Graf, K., Law, R.E., Fleck, E., and Grafe, M. (2002) PPAR activators inhibit endothelial cell migration by targeting Akt. Biochem. Biophys. Res. Commun. 293(5), 1431-1437.
63. Bishop-Bailey, D. (2000) Peroxisome proliferator-activated receptors in the cardiovascular system. Br. J. Pharmacol. 129(5), 823-834.
64. Marx, N., Bourcier, T., Sukhova, G.K., Libby, P., and Plutzky, J. (1999) PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler. Thromb. Vasc. Biol. 19(3), 546-551.
65. Plutzky, J. (1999) Atherosclerotic plaque rupture: emerging insights and opportunities. Am. J. Cardiol. 84(1A), 15J-20J.
66. Ricote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witztum, J.L., Auwerx, J., Palinski, W., and Glass, C.K. (1998) Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 95(13), 7614-7619.
67. Jiang, C., Ting, A.T., and Seed, B. (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391(6662), 82-86.
68. Takata, Y., Kitami, Y., Yang, Z.H., Nakamura, M., Okura, T., and Hiwada, K. (2002) Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferatoractivated receptor-gamma. Circ. Res. 91(5), 427-433.
69. Haffner, S.M., Greenberg, A.S., Weston, W.M., Chen, H., Williams, K., and Freed, M.I. (2002) Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106(6), 679-684.
70. Koshiyama, H., Shimono, D., Kuwamura, N., Minamikawa, J., and Nakamura, Y. (2001) Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J. Clin. Endocrinol. Metab. 86(7), 3452-3456.
71. Minamikawa, J., Tanaka, S., Yamauchi, M., Inoue, D., and Koshiyama, H. (1998) Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J. Clin. Endocrinol. Metab. 83(5), 1818-1820.
72. Hirai, H., Tanaka, K., Takano, S., Ichimasa, M., Nakamura, M., and Nagata, K. (2002) Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. J. Immunol. 168(3), 981-985.
73. Monneret, G., Gravel, S., Diamond, M., Rokach, J., and Powell, W.S. (2001) Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98(6), 1942-1948.
74. Sawyer, N., Cauchon, E., Chateauneuf, A., Cruz, R.P., Nicholson, D.W., Metters, K.M., O'Neill, G.P, and Gervais, F.G. (2002) Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br. J. Pharmacol. 137(8), 1163-1172.
75. Monneret, G., Cossette, C., Gravel, S., Rokach, J., and Powell, W.S. (2003) 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils. J. Pharmacol. Exp. Ther. 304(1), 349-355.
76. Bohm, E., Sturm, G.J., Weiglhofer, I., Sandig, H., Shichijo, M., McNamee, A., Pease, J.E., Kollroser, M., Peskar, B.A., and Heinemann, A. (2004) 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J. Biol. Chem. 279(9), 7663-7670.
77. Sugimoto, H., Shichijo, M., Iino, T., Manabe, Y., Watanabe, A., Shimazaki, M., Gantner, F., and Bacon, K.B. (2003) An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J. Pharmacol. Exp. Ther. 305(1), 347-352.
78. Gervais, F.G., Cruz, R.P., Chateauneuf, A., Gale, S., Sawyer, N., Nantel, F., Metters, K.M., and O'Neill, G.P. (2001) Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J. Allergy Clin. Immunol. 108(6), 982-988.
79. Trist, D.G., Collins, B.A., Wood, J., Kelly, M.G., and Robertson, A.D. (1989) The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. Br. J. Pharmacol. 96(2), 301-306.
80. Romagnani, S. (2002) Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 38(12-13), 881-885.
81. Lou, J., Buhler, L., Deng, S., Mentha, G., Montesano, R., Grau, G.E., and Morel, P. (1998) Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1. Hepatology 27(3), 822-828.
82. Oppenheimer-Marks, N., Kavanaugh, A.F., and Lipsky, P.E. (1994) Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2. J. Immunol. 152(12), 5703-5713.
83. Armstrong, R.A. (1996) Platelet prostanoid receptors. Pharmacol. Ther. 72(3), 171-191.
84. Brezinski, M.E., Lefer, D.J., Bowker, B., and Lefer, A.M. (1987) Thromboxane induced red blood cell lysis. Prostaglandins 33(1), 75-84.
85. Dutta-Roy, A.K., Kahn, N.N., and Sinha, A.K. (1991) Interaction of receptors for prostaglandin E1/prostacyclin and insulin in human erythrocytes and platelets. Life Sci. 49(16), 1129-1139.
86. Mita, H., Hasegawa, M., Higashi, N., and Akiyama, K. (2002) Characterization of PGE2 receptor subtypes in human eosinophils. J. Allergy Clin. Immunol. 110(3), 457-459.
87. Wheeldon, A. and Vardey, C.J. (1993) Characterization of the inhibitory prostanoid receptors on human neutrophils. Br. J. Pharmacol. 108(4), 1051-1054.
88. Armstrong, R.A. (1995) Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils. Br. J. Pharmacol. 116(7), 2903-2908.
89. Virgolini, I., Li, S., Sillaber, C., Majdic, O., Sinzinger, H., Lechner, K., Bettelheim, P., and Valent, P. (1992) Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor. J. Biol. Chem. 267(18), 12700-12708.
90. Abdel-Majid, R.M. and Marshall, J.S. (2004) Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J. Immunol. 172(2), 1227-1236.
91. Meja, K.K., Barnes, P.J., and Giembycz, M.A. (1997) Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Br. J. Pharmacol. 122(1), 149-157.
92. Kubo, S., Takahashi, H.K., Takei, M., Iwagaki, H., Yoshino, T., Tanaka, N., Mori, S., and Nishibori, M. (2004) Eprostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization. J. Pharmacol. Exp. Ther. 309(3), 1213-1220.
93. Morichika, T., Takahashi, H.K., Iwagaki, H., Yagi, T., Saito, S., Kubo, S., Yoshino, T., Akagi, T., Mori, S., Nishibori, M., and Tanaka, N. (2003) Effect of prostaglandin E2 on intercellular adhesion molecule-1 and B7 expression in mixed lymphocyte reaction. Transplantation 75(12), 2100-2105.
94. Hinz, B., Brune, K., and Pahl, A. (2000) Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Biochem. Biophys. Res. Commun. 278(3), 790-796.
95. Iwasaki, K., Noguchi, K., Endo, H., Kondo, H., and Ishikawa, I. (2003) Prostaglandin E2 downregulates interleukin-12 production through EP4 receptors in human monocytes stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans and interferon-gamma. Oral Microbiol. Immunol. 18(3), 150-155.
96. Zeng, L., An, S., and Goetzl, E.J. (1995) Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells. Immunology 86(4), 620-628.
97. Hoper, M.M., Voelkel, N.F., Bates, T.O., Allard, J.D., Horan, M., Shepherd, D., and Tuder, R.M. (1997) Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am. J. Respir. Cell Mol. Biol. 17(6), 748-756.
98. Wagner, R.S., Halushka, P.V., and Cook, J.A. (1996) Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. Shock 5(1), 41-46.
99. Takayama, K., Garcia-Cardena, G., Sukhova, G.K., Comander, J., Gimbrone, M.A., Jr., and Libby, P. (2002) Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J. Biol. Chem. 277(46), 44147-44154.
100. Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K.A., Maliszewski, C., Shortman, K., Cebon, J., and Maraskovsky, E. (2002) Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100(4), b1362-1372.
101. Mori, K., Tanaka, I., Kotani, M., Miyaoka, F., Sando, T., Muro, S., Sasaki, Y., Nakagawa, O., Ogawa, Y., Usui, T., Ozaki, S., Ichikawa, A., Narumiya, S., and Nakao, K. (1996) Gene expression of the human prostaglandin E receptor EP4 subtype: differential regulation in monocytoid and lymphoid lineage cells by phorbol ester. J. Mol. Med. 74(6), 333-336.
102. Zeng, L., An, S., and Goetzl, E.J. (1996) Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor. J. Biol. Chem. 271(44), 27744-27750.
103. Cosme, R., Lublin, D., Takafuji, V., Lynch, K., and Roche, J.K. (2000) Prostanoids in human colonic mucosa: effects of inflammation on PGE(2) receptor expression. Hum. Immunol. 61(7), 684-696.
104. Zeng, L., An, S., and Goetzl, E.J. (1998) EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells. J. Pharmacol. Exp. Ther. 286(3), 1420-1426.
105. Goetzl, E.J., An, S., and Zeng, L. (1995) Specific suppression by prostaglandin E2 of activation-induced apoptosis of human CD4+CD8+ T lymphoblasts. J. Immunol. 154(3), 1041-1047.
106. Clapp, L.H., Finney, P., Turcato, S., Tran, S., Rubin, L.J., and Tinker, A. (2002) Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. Am. J. Respir. Cell Mol. Biol. 26(2), 194-201.
107. Meyer-Kirchrath, J., Debey, S., Glandorff, C., Kirchrath, L., and Schror, K. (2004) Gene expression profile of the Gs-coupled prostacyclin receptor in human vascular smooth muscle cells. Biochem. Pharmacol. 67(4), 757-765.
108. Debey, S., Kirchrath, L., Schror, K., and Meyer-Kirchrath, J. (2003) Iloprost down-regulates the expression of the growth regulatory gene Cyr61 in human vascular smooth muscle cells. Eur. J. Pharmacol. 474(2-3), 161-164.
109. Walton, L.J., Franklin, I.J., Bayston, T., Brown, L.C., Greenhalgh, R.M., Taylor, G.W., and Powell, J.T. (1999) Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 100(1), 48-54.
110. Proudfoot, D., Fitzsimmons, C., Torzewski, J., and Bowyer, D.E. (1999) Inhibition of human arterial smooth muscle cell growth by human monocyte/macrophages: a co-culture study. Atherosclerosis 145(1), 157-165.
111. Goncharova, E.A., Billington, C.K., Irani, C., Vorotnikov, A.V., Tkachuk, V.A., Penn, R.B., Krymskaya, V.P., and Panettieri, R.A., Jr. (2003) Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration. Am. J. Respir. Cell Mol. Biol. 29(1), 19-27.
112. Kuwano, T., Nakao, S., Yamamoto, H., Tsuneyoshi, M., Yamamoto, T., Kuwano, M., and Ono, M. (2004) Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J. 18(2), 300-310.
113. Leahy, K.M., Ornberg, R.L., Wang, Y., Zweifel, B.S., Koki, A.T., and Masferrer, J.L. (2002) Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 62(3), 625-631.
114. Jones, M.K., Wang, H., Peskar, B.M., Levin, E., Itani, R.M., Sarfeh, I.J., and Tarnawski, A.S. (1999) Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat. Med. 5(12), 1418-1423.
115. Sennlaub, F., Valamanesh, F., Vazquez-Tello, A., El-Asrar, A.M., Checchin, D., Brault, S., Gobeil, F., Beauchamp, M.H., Mwaikambo, B., Courtois, Y., Geboes, K., Varma, D.R., Lachapelle, P., Ong, H., Behar-Cohen, F., and Chemtob, S. (2003) Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation 108(2), 198-204.
116. Chi-Man Tang, T., Tung-Ping Poon, R., and Fan, S.T. (2005) The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma. Biomed. Pharmacother. 59(Suppl 2), S311-316.
117. Mobius, C., Stein, H.J., Spiess, C., Becker, I., Feith, M., Theisen, J., Gais, P., Jutting, U., and Siewert, J.R. (2005) COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer. Eur. J. Surg. Oncol. 31(7), 755-759.
118. Marrogi, A.J., Travis, W.D., Welsh, J.A., Khan, M.A., Rahim, H., Tazelaar, H., Pairolero, P., Trastek, V., Jett, J., Caporaso, N.E., Liotta, L.A., and Harris, C.C. (2000) Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin. Cancer Res. 6(12), 4739-4744.
119. Tang, T.C., Poon, R.T., Lau, C.P., Xie, D., and Fan, S.T. (2005) Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J. Gastroenterol. 11(13), 1896-1902.
120. Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., Murata, T., Yoshimura, H., Narumiya, S., and Majima, M. (2003) Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J. Exp. Med. 197(2), 221-232.
121. Coleman, R.A., Smith, W.L., and Narumiya, S. (1994) International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46(2), 205-229.
122. Abramovitz, M., Adam, M., Boie, Y., Carriere, M., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N.M., Belley, M., Gallant, M., Dufresne, C., Gareau, Y., Ruel, R., Juteau, H., Labelle, M., Ouimet, N., and Metters, K.M. (2000) The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483(2), 285-293.
123. Wilson, R.J. and Giles, H. (2005) Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes. Br. J. Pharmacol. 144(3), 405-415.
124. Wilson, R.J., Rhodes, S.A., Wood, R.L., Shield, V.J., Noel, L.S., Gray, D.W., and Giles, H. (2004) Functional pharmacology of human prostanoid EP2 and EP4 receptors. Eur. J. Pharmacol. 501(1-3), 49-58.
125. Angulo, J., Cuevas, P., La Fuente, J.M., Pomerol, J.M., Ruiz-Castane, E., Puigvert, A., Gabancho, S., Fernandez, A., Ney, P., and Saenz De Tejada, I. (2002) Regulation of human penile smooth muscle tone by prostanoid receptors. Br. J. Pharmacol. 136(1), 23-30.
126. Baxter, G.S., Clayton, J.K., Coleman, R.A., Marshall, K., Sangha, R., and Senior, J. (1995) Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery. Br. J. Pharmacol. 116(1), 1692-1696.
127. Davis, R.J., Murdoch, C.E., Ali, M., Purbrick, S., Ravid, R., Baxter, G.S., Tilford, N., Sheldrick, R.L., Clark, K.L., and Coleman, R.A. (2004) EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br. J. Pharmacol. 141(4), 580-585.
128. Qian, Y.M., Jones, R.L., Chan, K.M., Stock, A.I., and Ho, J.K. (1994) Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery. Br. J. Pharmacol. 113(2), 369-374.
129. Walch, L., de Montpreville, V., Brink, C., and Norel, X. (2001) Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins. Br. J. Pharmacol. 134(8), 1671-1678.
130. Walch, L., Labat, C., Gascard, J.P., de Montpreville, V., Brink, C., and Norel, X. (1999) Prostanoid receptors involved in the relaxation of human pulmonary vessels. Br. J. Pharmacol. 126(4), 859-866.
131. Martin-Ventura, J.L., Blanco-Colio, L.M., Gomez-Hernandez, A., Munoz-Garcia, B., Vega, M., Serrano, J., Ortega, L., Hernandez, G., Tunon, J., and Egido, J. (2005) Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Stroke 36(8), 1796-1800.
132. Jouve, R., Rolland, P.H., Delboy, C., and Mercier, C. (1984) Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy. Am. Heart J. 107(1), 45-52.
133. Parsons, A.A. and Whalley, E.T. (1989) Effects of prostanoids on human and rabbit basilar arteries precontracted in vitro. Cephalalgia 9(3), 165-171.
134. Uski, T.K., Andersson, K.E., Brandt, L., and Ljunggren, B. (1984) Characterization of the prostanoid receptors and of the contractile effects of prostaglandin F2 alpha in human pial arteries. Acta Physiol. Scand. 121(4), 369-378.
135. Hempelmann, R.G., Barth, H.L., Mehdorn, H.M., Pradel, R.H., and Ziegler, A. (1995) Effects of potassium channel openers in isolated human cerebral arteries. Neurosurgery 37(6), 1146-1153.
136. Spada, C.S., Nieves, A.L., and Woodward, D.F. (2002) Vascular activities of prostaglandins and selective prostanoid receptor agonists in human retinal microvessels. Exp. Eye Res. 75(2), 155-163.
137. Ohlstein, E.H., Kopia, G.A., Zeid, R.L., Valocik, R.W., Horohonich, S., Hieble, J.P., and Wasserman, M.A. (1988) Effects of the thromboxane receptor antagonist SK&F 88046 in the canine, monkey and human coronary vasculature. Prostaglandins 36(1), 69-84.
138. Merritt, J.E., Brown, A.M., Bund, S., Cooper, D.G., Egan, J.W., Hallam, T.J., Heagerty, A.M., Hickey, D.M., Kaumann, A.J., Keen, M., et al. (1991) Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor. Br. J. Pharmacol. 102(1), 260-266.
139. Cocks, T.M., Kemp, B.K., Pruneau, D., and Angus, J.A. (1993) Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Br. J. Pharmacol. 110(1), 360-368.
140. Champion, H.C., Bivalacqua, T.J., Pierce, R.L., Murphy, W.A., Coy, D.H., Hyman, A.L., and Kadowitz, P.J. (2003) Responses to human CGRP, ADM, and PAMP in human thymic arteries. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284(2), R531-537.
141. Maddox, Y., Cunard, C.M., Shapiro, R., Kawaguchi, A., Goldman, M., and Lower, R.R. (1985) A Comparison of the Contractile Responses of Rodent and Human Pulmonary Vascular Segments to Eicosanoids.: Elsevier.
142. Haye-Legrand, I., Bourdillat, B., Labat, C., Cerrina, J., Norel, X., Benveniste, J., and Brink, C. (1987) Relaxation of isolated human pulmonary muscle preparations with prostacyclin (PGI2) and its analogs. Prostaglandins 33(6), 845-854.
143. Norel, X., Labat, C., Gardiner, P.J., and Brink, C. (1991) Inhibitory
144. Kamper, A.M., Paul, L.C., and Blauw, G.J. (2002) Prostaglandins are involved in acetylcholine- and 5-hydroxytryptamine-induced, nitric oxide-mediated vasodilatation in human forearm. J. Cardiovasc. Pharmacol. 40(6), 922-929.
145. Arner, M. and Hogestatt, E.D. (1991) Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries. Acta Physiol. Scand. 142(2), 165-172.
146. Arner, M., Hogestatt, E.D., and Uski, T.K. (1991) Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848. Acta Physiol. Scand. 141(1), 79-86.
147. Bjoro, K. and Stray-Pedersen, S. (1986) Effects of vasoactive autacoids on different segments of human umbilicoplacental vessels. Gynecol. Obstet. Invest. 22(1), 1-6.
148. Boura, A.L., Gude, N.M., King, R.G., Mak, K.K., and Walters, W.A. (1986) Characterization of thromboxane A2 receptors in the human fetal placental vessels and umbilical vein. Clin. Exp. Pharmacol. Physiol. 13(1), 83-86.
149. Boersma, J.I., Janzen, K.M., Oliveira, L., and Crankshaw, D.J. (1999) Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br. J. Pharmacol. 128(7), 1505-1512.
150. Daray, F.M., Minvielle, A.I., Puppo, S., and Rothlin, R.P. (2003) Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein. Br. J. Pharmacol. 139(8), 1409-1416.
151. Cracowski, J.L., Stanke-Labesque, F., Sessa, C., Hunt, M., Chavanon, O., Devillier, P., and Bessard, G. (1999) Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein. Can. J. Physiol. Pharmacol. 77(10), 770-776.
152. Furci, L., Fitzgerald, D.J., and Fitzgerald, G.A. (1991) Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J. Pharmacol. Exp. Ther. 258(1), 74-81.
153. McLaughlin, V.V., Gaine, S.P., Barst, R.J., Oudiz, R.J., Bourge, R.C., Frost, A., Robbins, I.M., Tapson, V.F., McGoon, M.D., Badesch, D.B., Sigman, J., Roscigno, R., Blackburn, S.D., Arneson, C., Rubin, L.J., and Rich, S. (2003) Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. J. Cardiovasc. Pharmacol. 41(2), 293-299.
154. Sussmann, M., Sarbia, M., Meyer-Kirchrath, J., Nusing, R.M., Schror, K., and Fischer, J.W. (2004) Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins. Circ. Res. 94(5), 592-600.
155. Cipollone, F., Fazia, M.L., Iezzi, A., Cuccurullo, C., De Cesare, D., Ucchino, S., Spigonardo, F., Marchetti, A., Buttitta, F., Paloscia, L., Mascellanti, M., Cuccurullo, F., and Mezzetti, A. (2005) Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler. Thromb. Vasc. Biol. 25(9), 1925-1931.
156. Inoue, H., Takamori, M., Shimoyama, Y., Ishibashi, H., Yamamoto, S., and Koshihara, Y. (2002) Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts. Br. J. Pharmacol. 136(2), 287-295.
157. Schmitz, T., Leroy, M.J., Dallot, E., Breuiller-Fouche, M., Ferre, F., and Cabrol, D. (2003) Interleukin-1beta induces glycosaminoglycan synthesis via the prostaglandin E2 pathway in cultured human cervical fibroblasts. Mol. Hum. Reprod. 9(1), 1-8.
158. Haveman, J.W., van den Berg, A.P., Verhoeven, E.L., Nijsten, M.W., van den Dungen, J.J., The, H.T., and Zwaveling, J.H. (2006) HLA-DR expression on monocytes and systemic inflammation in patients with ruptured abdominal aortic aneurysms. Crit. Care 10(4), R119.
159. Gudmundsson, G., Matthiasson, S.E., Arason, H., Johannsson, H., Runarsson, F., Bjarnason, H., Helgadottir, K., Thorisdottir, S., Ingadottir, G., Lindpaintner, K., Sainz, J., Gudnason, V., Frigge, M.L., Kong, A., Gulcher, J.R., and Stefansson, K. (2002) Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am. J. Hum. Genet. 70(3), 586-592.
160. Norel, X., de Montpreville, V., and Brink, C. (2004) Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713. Prostaglandins Other Lipid Mediat. 74(1-4), 101-112.
161. Matsuoka, T. and Narumiya, S. (2007) Prostaglandin receptor signaling in disease. TheScientificWorldJOURNAL 7, 1329-1347.